Preoperative relative cerebral blood volume analysis in gliomas predicts survival and mitigates risk of biopsy sampling error
暂无分享,去创建一个
Brendan J. McCullough | D. Newell | R. Gwinn | C. Cobbs | J. Henson | B. Keogh | S. Monteith | M. Mayberg | J. Delashaw | Xu Feng | S. Rostad | S. Fouke | Tara L. Benkers | D. Susanto | Brian Aguedan | Valerie Ader | B. McCullough
[1] J. Mercier,et al. Preoperative Prognostic Value of Dynamic Contrast-Enhanced MRI–Derived Contrast Transfer Coefficient and Plasma Volume in Patients with Cerebral Gliomas , 2015, American Journal of Neuroradiology.
[2] F. Gaillard,et al. MRI Grading versus Histology: Predicting Survival of World Health Organization Grade II–IV Astrocytomas , 2015, American Journal of Neuroradiology.
[3] Susan M. Chang,et al. Report of the Jumpstarting Brain Tumor Drug Development Coalition and FDA clinical trials neuroimaging endpoint workshop (January 30, 2014, Bethesda MD). , 2014, Neuro-oncology.
[4] Z. Rumboldt,et al. Correlation between Cerebral Blood Volume Measurements by Perfusion-Weighted Magnetic Resonance Imaging and Two-Year Progression-Free Survival in Gliomas , 2013, The neuroradiology journal.
[5] Xin Li,et al. High-Resolution Steady-State Cerebral Blood Volume Maps in Patients with Central Nervous System Neoplasms Using Ferumoxytol, a Superparamagnetic Iron Oxide Nanoparticle , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[6] J. Debbins,et al. Correlations between Perfusion MR Imaging Cerebral Blood Volume, Microvessel Quantification, and Clinical Outcome Using Stereotactic Analysis in Recurrent High-Grade Glioma , 2012, American Journal of Neuroradiology.
[7] Susan M. Chang,et al. Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] Douglas C. Miller,et al. Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. , 2008, Radiology.
[9] T Metens,et al. Stereotactic comparison among cerebral blood volume, methionine uptake, and histopathology in brain glioma. , 2007, AJNR. American journal of neuroradiology.
[10] Glyn Johnson,et al. Low-grade gliomas: dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging--prediction of patient clinical response. , 2006, Radiology.
[11] Glyn Johnson,et al. Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. , 2004, AJNR. American journal of neuroradiology.
[12] Ying Lu,et al. Survival analysis in patients with glioblastoma multiforme: Predictive value of choline‐to‐n‐acetylaspartate index, apparent diffusion coefficient, and relative cerebral blood volume , 2004, Journal of magnetic resonance imaging : JMRI.
[13] Michael H Lev,et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.
[14] Glyn Johnson,et al. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. , 2003, AJNR. American journal of neuroradiology.
[15] A. Friedman,et al. MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. , 2003, Surgical neurology.
[16] G. Fuller,et al. Limitations of stereotactic biopsy in the initial management of gliomas. , 2001, Neuro-oncology.
[17] F. Abdul-Karim,et al. Interobserver reproducibility among neuropathologists and surgical pathologists in fibrillary astrocytoma grading , 2000, Journal of the Neurological Sciences.
[18] G Johnson,et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.
[19] M Takahashi,et al. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. , 1998, AJR. American journal of roentgenology.
[20] D K Pearl,et al. Improving diagnostic accuracy and interobserver concordance in the classification and grading of primary gliomas , 1997, Cancer.
[21] E G Stopa,et al. Observer reliability in histological grading of astrocytoma stereotactic biopsies. , 1996, Journal of neurosurgery.
[22] E F Halpern,et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.
[23] A. Friedman,et al. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas , 1991, Neurology.
[24] Maurice M. Smith,et al. Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. , 1989, Neurosurgery.
[25] S. Ekholm,et al. Correlation between progression free survival and dynamic susceptibility contrast MRI perfusion in WHO grade III glioma subtypes , 2013, Journal of Neuro-Oncology.